TrialObstetrics and gynecology2024

Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia.

What the trial testedas reported · 831 people · 2024

Range includes no effect

+4%−30% to +56%

Bigger than 1 in 10 on the map

As reported

OR 1.04, 95% CI 0.70–1.56

Range includes no effect

1.4×0.7× to 2.8×

5 in 100 instead of 4

Bigger than 6 in 10 on the map

As reported

OR 1.43, 95% CI 0.73–2.81

the abstract, start to end

… of gestation (adjusted odds ratio [aOR] 1.04, 95% CI, 0.70-1.56) or before 34 weeks (aOR 1.43, 95% CI, 0.73-2.81).

← favours treatmentfavours comparator →

could be chance

Pregnancy & neonatal

OR 1.040.70–1.56

Pregnancy & neonatal

OR 1.430.73–2.81

MetforminPregnancy & neonatal

Metformin × pregnancy & neonatalhelps?mixed

unlikelylikely

0.000.00 without it

← favours treatmentfavours comparator →

this papermore certainless certain

1 / 5

2024

2025

2026

this paperpooled itcites it